Markets:

Overview

News

Currencies

International

Treasuries

Avalo Therapeutics, Inc. - Common Stock (NQ:AVTX)

14.73 +0.33 (+2.33%)

Streaming Delayed Price Updated: 10:35 AM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Avalo Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

71 Biggest Movers From Yesterday ↗

April 27, 2022

Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (...

Via Benzinga

4 Penny Stocks Insiders Are Buying ↗

March 01, 2022

China’s official NBS manufacturing PMI rose to 50.2 in February from January's figure of 50.1. Investors, meanwhile, focused on some nota...

Via Benzinga

55 Biggest Movers From Friday ↗

April 04, 2022

Gainers Takung Art Co., Ltd. (NASDAQ: TKAT) surged 61.8% to close at $3.64 on Friday. Chicken Soup for the Soul Entertainment, Inc. (NASDAQ: CSSE) rose 43.8% to settle at $11.49...

Via Benzinga

5 Penny Stocks Insiders Are Buying ↗

February 23, 2022

Annual inflation rate in the Eurozone was confirmed at a record level of 5.1% for January. Investors, meanwhile, focused on some notable insider tr...

Via Benzinga

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Investor Alert: Investigation over Potential Wrongdoing ↗

February 17, 2022

San Diego, CA -- (SBWIRE) -- 02/17/2022 -- Certain directors of Avalo Therapeutics, Inc f.k.a. Cerecor Inc are under investigation over potential breaches of fiduciary duties.

Via SBWire

Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022 ↗

March 03, 2022

Upgrades For Douglas Emmett Inc (NYSE:DEI), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the fourth quarter, Douglas Emmett had an EPS of $0.48,...

Via Benzinga

NASDAQ: AVTX Shareholder Notice: Investigation over Possible Securities Laws Violations by Avalo Therapeutics, Inc. ↗

February 04, 2022

San Diego, CA -- (SBWIRE) -- 02/04/2022 -- An investigation for investors in Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares over potential securities laws violations by Avalo Therapeutics, Inc. was...

Via SBWire

4 Penny Stocks Insiders Are Buying: CymaBay Therapeutics, Avalo Therapeutics And More ↗

January 21, 2022

US stock futures traded lower this morning after Netflix, Inc. (NASDAQ:

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

January 18, 2022

Gainers Brickell Biotech (NASDAQ:BBI) shares rose 37.0% to $0.28 during Tuesday's pre-market session. The market value of their outstanding shares is at $32.7 million...

Via Benzinga

5 Penny Stocks Insiders Are Buying ↗

January 18, 2022

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...

Via Benzinga

3 Penny Stocks Insiders Are Buying ↗

January 12, 2022

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

January 07, 2022

Gainers Absci (NASDAQ:ABSI) stock increased by 28.2% to $7.87 during Friday's regular session. As of 12:30 EST, Absci's stock is trading at a volume of 38.6...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 06, 2022

Gainers Eargo (NASDAQ:EAR) stock increased by 50.0% to $6.84 during Thursday's regular session. The current volume of 90.4 million shares is 5474.6% of Eargo's...

Via Benzinga

56 Biggest Movers From Friday ↗

January 10, 2022

Gainers Hour Loop, Inc. (NASDAQ: HOUR) shares jumped 99.8% to $7.99 after the company priced its IPO at $4 per share. China HGS Real Estate Inc. (NASDAQ: HGSH) shares...

Via Benzinga

The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales ↗

January 06, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Illumina Announces Co-Development Partnership With SomaScan For Accelerating...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

January 07, 2022

Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap...

Via Benzinga

58 Biggest Movers From Yesterday ↗

January 07, 2022

Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the company announced the Department of Justice confirmed to it that the previously-...

Via Benzinga

The Week Ahead In Biotech (Jan. 2-Jan. 8): Stray Clinical Readouts In Focus In Slow News Week ↗

January 02, 2022

Biotech stocks came under selling pressure in the final week of 2021, although they carved out modest gains for the year. Here are the key catalysts that can sway biotech stocks in the unfolding week.

Via Talk Markets

The Week Ahead In Biotech (Jan 2-Jan. 8): Stray Clinical Readouts In Focus In Slow News Week ↗

January 02, 2022

Biotech stocks came under selling pressure in the final week of 2021, although they carved out modest gains for the year. On the regulatory front, the Food And Drug Administration...

Via Benzinga

The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus ↗

December 26, 2021

Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts, and COVID-19 treatment and vaccine developments dictating sentiment. Here are the key...

Via Talk Markets

The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year ↗

December 26, 2021

Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts and COVID-19 treatment and vaccine developments dictating...

Via Benzinga

Investigation for Long-Term Investors in Avalo Therapeutics, Inc. (NASDAQ:AVTX) Shares Announced ↗

December 15, 2021

San Diego, CA -- (SBWIRE) -- 12/15/2021 -- Avalo Therapeutics, Inc f.k.a. Cerecor Inc is under investigation over potential securities laws violations in connection with certain financial statements.

Via SBWire

4 Penny Stocks Insiders Are Buying ↗

December 15, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...

Via Benzinga

NASDAQ: AVTX Investor Notice: Investigation over Potential Wrongdoing at Avalo Therapeutics, Inc f.k.a. Cerecor Inc ↗

November 29, 2021

San Diego, CA -- (SBWIRE) -- 11/29/2021 -- An investigation on behalf of investors in Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares over potential wrongdoing at Avalo Therapeutics, Inc. was...

Via SBWire

NASDAQ:AVTX Investor Notice: Investigation over Potential Securities Laws Violations by Avalo Therapeutics, Inc. ↗

November 09, 2021

San Diego, CA -- (SBWIRE) -- 11/09/2021 -- An investigation was announced for investors of Avalo Therapeutics, Inc. (NASDAQ:AVTX) shares over potential securities laws violations by Avalo Therapeutics,...

Via SBWire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 06, 2021

Gainers Voyager Therapeutics (NASDAQ:VYGR) shares increased by 46.15% to $3.61 during Wednesday's pre-market session. The company's market cap stands at $136.9...

Via Benzinga

4 Penny Stocks Insiders Are Buying ↗

September 20, 2021

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 24, 2021 ↗

September 24, 2021

Upgrades Berenberg upgraded the previous rating for Tenable Holdings Inc (NASDAQ:

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 17, 2021

Gainers Corvus Pharmaceuticals (NASDAQ:CRVS) stock moved upwards by 53.98% to $3.48 during Friday's pre-market session. The company's market cap stands at $147.6...

Via Benzinga

53 Biggest Movers From Yesterday ↗

September 16, 2021

Gainers DICE Therapeutics, Inc. (NASDAQ: DICE) shares surged 117% to settle at $36.89 on Wednesday as the company priced its IPO at $17 per share. PROCEPT BioRobotics Corporation...

Via Benzinga

Topics Initial Public Offering

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Avalo Therapeutics, Inc. - Common Stock (NQ:AVTX)

All News about Avalo Therapeutics, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today